Additionally, significant and progressive increases in age, BMI, HbA1c, HOMA-IR, TG, TC, LDL-C, WBC, RBC, Hb, NEU, LYM, MONO, ALT, AST, γ-GT, ALB, GLB, and TSH levels were found in the non-NAFLD and NAFLD groups (p < 0.05 and p < 0.01, respectively). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.